Practical Approach for the Clinical Use of Dopamine Transporter Imaging.
- Author:
Jae Seung KIM
1
Author Information
1. Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, Korea. jaeskim@amc.seoul.kr
- Publication Type:Review
- Keywords:
Dopamine transporter;
Parkinson's disease;
positron emission tomography;
single photon emission computed tomography;
drug;
analysis
- MeSH:
Dopamine;
Dopamine Plasma Membrane Transport Proteins;
Korea;
Parkinson Disease;
Positron-Emission Tomography;
Radiopharmaceuticals;
Sensory Receptor Cells;
Taiwan;
Tomography, Emission-Computed, Single-Photon;
Tropanes
- From:Nuclear Medicine and Molecular Imaging
2008;42(6):425-434
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Dopamine transporter imaging is useful in the diagnosis of Parkinson's disease and the most successful technique in the clinical use of neuroreceptor imaging. Recently, several radiopharmaceuticals including I-123 FP-CIT, Tc-99m TRODAT, and F-18 FP-CIT for dopamine transporter imaging have been approved for the routine clinical use in several European countries, Taiwan and Korea, respectively. This review summarized the practical issue for the routine clinical examination of dopamine transporter imaging.
